לנלידומיד אס.קיי. 7.5 מג
k.s.kim international (sk- pharma) ltd., israel - lenalidomide - קפסולה קשיחה - lenalidomide 7.5 mg - lenalidomide
לנלידומיד אס.קיי.15 מג
k.s.kim international (sk- pharma) ltd., israel - lenalidomide - קפסולה קשיחה - lenalidomide 15 mg - lenalidomide
לנלידומיד אס.קיי.20 מג
k.s.kim international (sk- pharma) ltd., israel - lenalidomide - קפסולה קשיחה - lenalidomide 20 mg - lenalidomide
קלטרה תמיסה לשתייה
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
קלטרה 100 מג25 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - lopinavir 100 mg; ritonavir 25 mg - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infections.
קלטרה 200 מג50 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
קלטרה 200 מג50 מג טבליות
abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - טבליות מצופות פילם - ritonavir 50 mg; lopinavir 200 mg - lopinavir - lopinavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.
רבלימיד 5 מ"ג
neopharm scientific ltd - lenalidomide 5 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
רבלימיד 10 מ"ג
neopharm scientific ltd - lenalidomide 10 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.
רבלימיד 15 מ"ג
neopharm scientific ltd - lenalidomide 15 mg - capsules - lenalidomide - 1. treatment of patients with transfusion-dependent anemia due to low- or intermediate - 1 - risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormality. 2. in combination with dexamethasone treatment of multiple myeloma patient who have received at least one prior therapy.